Synthesis and Comparative In Vivo Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET

[Image: see text] Delta-like ligand 3 (DLL3) is a therapeutic target for the treatment of small cell lung cancer, neuroendocrine prostate cancer, and isocitrate dehydrogenase mutant glioma. In the clinic, DLL3-targeted (89)Zr-immunoPET has the potential to aid in the assessment of disease burden and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Sai Kiran, Adumeau, Pierre, Keinänen, Outi, Sisodiya, Vikram, Sarvaiya, Hetal, Tchelepi, Robert, Korsen, Joshua A, Pourat, Jacob, Edwards, Kimberly J., Ragupathi, Ashwin, Hamdy, Omar, Saunders, Laura R., Rudin, Charles M., Poirier, John T., Lewis, Jason S., Zeglis, Brian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295218/
https://www.ncbi.nlm.nih.gov/pubmed/33835770
http://dx.doi.org/10.1021/acs.bioconjchem.1c00121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295218/
https://www.ncbi.nlm.nih.gov/pubmed/33835770
http://dx.doi.org/10.1021/acs.bioconjchem.1c00121

Ejemplares similares